CA2889592A1 - Process for preparing bile acid derivatives - Google Patents

Process for preparing bile acid derivatives Download PDF

Info

Publication number
CA2889592A1
CA2889592A1 CA2889592A CA2889592A CA2889592A1 CA 2889592 A1 CA2889592 A1 CA 2889592A1 CA 2889592 A CA2889592 A CA 2889592A CA 2889592 A CA2889592 A CA 2889592A CA 2889592 A1 CA2889592 A1 CA 2889592A1
Authority
CA
Canada
Prior art keywords
compound
formula
pharmaceutically acceptable
preparing
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2889592A
Other languages
English (en)
French (fr)
Inventor
Roberto Pellicciari
Antimo GIOIELLO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intercept Pharmaceuticals Inc
Original Assignee
Intercept Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercept Pharmaceuticals Inc filed Critical Intercept Pharmaceuticals Inc
Publication of CA2889592A1 publication Critical patent/CA2889592A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA2889592A 2012-10-26 2013-10-25 Process for preparing bile acid derivatives Abandoned CA2889592A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261718966P 2012-10-26 2012-10-26
US61/718,966 2012-10-26
PCT/US2013/066917 WO2014066819A1 (en) 2012-10-26 2013-10-25 Process for preparing bile acid derivatives

Publications (1)

Publication Number Publication Date
CA2889592A1 true CA2889592A1 (en) 2014-05-01

Family

ID=50545344

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2889592A Abandoned CA2889592A1 (en) 2012-10-26 2013-10-25 Process for preparing bile acid derivatives

Country Status (22)

Country Link
US (2) US9777038B2 (enExample)
EP (1) EP2912013B1 (enExample)
JP (1) JP6272888B2 (enExample)
KR (1) KR102068381B1 (enExample)
CN (2) CN105102425B (enExample)
AU (1) AU2013334122B2 (enExample)
BR (1) BR112015009395A2 (enExample)
CA (1) CA2889592A1 (enExample)
CY (1) CY1119731T1 (enExample)
DK (1) DK2912013T3 (enExample)
ES (1) ES2655034T3 (enExample)
HK (1) HK1253301A1 (enExample)
HU (1) HUE036887T2 (enExample)
IL (1) IL238454B (enExample)
MX (1) MX361653B (enExample)
NO (1) NO2968302T3 (enExample)
NZ (2) NZ707389A (enExample)
PL (1) PL2912013T3 (enExample)
PT (1) PT2912013T (enExample)
SG (1) SG11201503247UA (enExample)
SM (1) SMT201700602T1 (enExample)
WO (1) WO2014066819A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ707389A (en) 2012-10-26 2018-08-31 Intercept Pharmaceuticals Inc Process for preparing bile acid derivatives
SI3626725T1 (sl) 2014-05-29 2023-04-28 Bar Pharmaceuticals S.R.L. Derivati holana za uporabo pri zdravljenju in/ali preprečevanju bolezni, posredovanih s FXR in TGR5/GPBAR1
KR102526632B1 (ko) 2014-11-19 2023-04-27 엔제트피 유케이 리미티드 스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 5β-6-알킬-7-하이드록시-3-온 스테로이드
EA033427B1 (ru) 2014-11-19 2019-10-31 Nzp Uk Ltd 6-алкил-7-гидрокси-4-ен-3-оновые стероиды в качестве промежуточных соединений для получения стероидных модуляторов fxr
ES2748692T3 (es) 2014-11-19 2020-03-17 Nzp Uk Ltd Esteroides 6.alfa.-alquil-3,7-diona como intermedios para la producción de moduladores FXR de esteroides
JP6698085B2 (ja) 2014-11-19 2020-05-27 エヌゼットピー ユーケー リミテッド ステロイドFXRモジュレーター製造のための中間体としての6α−アルキル−6,7−ジオン−ステロイド
CN104672290B (zh) * 2015-01-05 2017-06-06 北京普禄德医药科技有限公司 一种用于预防或治疗fxr‑介导的疾病的药物及其制备方法和用途
ES2905872T3 (es) 2015-02-06 2022-04-12 Intercept Pharmaceuticals Inc Composiciones farmacéuticas para terapia combinada
KR20180052756A (ko) 2015-09-24 2018-05-18 인터셉트 파마슈티컬즈, 인크. 담즙산 유도체 제조를 위한 방법 및 중간체
CN108348533A (zh) * 2015-11-06 2018-07-31 英特塞普特医药品公司 制备奥贝胆酸及其衍生物的方法
US20200262865A1 (en) * 2016-02-15 2020-08-20 Alexander Khoruts Compositions and methods for treating clostridium associated diseases
CA3020698A1 (en) 2016-04-13 2017-10-19 Intercept Pharmaceuticals, Inc. Methods of treating or preventing hepatocellular carcinoma
TW201738254A (zh) * 2016-04-19 2017-11-01 英特賽普醫藥品公司 奧貝膽酸及其衍生物之製備方法
GB201608777D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Compounds
GB201608776D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds
CN109963567A (zh) * 2016-09-30 2019-07-02 英特塞普特医药品公司 胆汁酸衍生物的结晶形式
CA3070837A1 (en) 2017-07-24 2019-01-31 Intercept Pharmaceuticals, Inc. Isotopically labeled bile acid derivatives
US11059854B2 (en) * 2017-07-26 2021-07-13 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Method for preparing steroid derivative FXR agonist
GB201812382D0 (en) 2018-07-30 2018-09-12 Nzp Uk Ltd Compounds
US20220226350A1 (en) 2019-05-30 2022-07-21 Intercept Pharmaceuticals, Inc. Pharmaceutical compositions comprising a fxr agonist and a fibrate for use in the treatment of cholestatic liver disease
JP2022552655A (ja) 2019-10-07 2022-12-19 キャリーオペ,インク. Gpr119アゴニスト
MX2022010548A (es) 2020-02-28 2022-09-23 Kallyope Inc Agonistas de gpr40.
MX2022014505A (es) 2020-05-19 2022-12-13 Kallyope Inc Activadores de la ampk.
CA3183575A1 (en) 2020-06-26 2021-12-30 Iyassu Sebhat Ampk activators
CN116249536B (zh) 2020-09-18 2026-05-19 沙裴隆有限公司 牛磺脱氧胆酸钠的批量生产方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216015A (en) * 1991-02-05 1993-06-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having hypocholesterolemic properties
DK1392714T3 (da) * 2001-03-12 2006-01-09 Intercept Pharmaceuticals Inc Steroider som agonister for FXR
EP1568706A1 (en) * 2004-02-26 2005-08-31 Intercept Pharmaceuticals, Inc. Novel steroid agonist for FXR
DK2040713T3 (da) * 2006-06-27 2014-09-29 Intercept Pharmaceuticals Inc Galdesyrederivater som fxr-ligander til forebyggelsen eller behandlingen af fxr-medierede sygdomme eller tilstande
WO2010036427A1 (en) 2008-06-17 2010-04-01 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
US8796249B2 (en) * 2008-07-30 2014-08-05 Intercept Pharmaceuticals, Inc. TGR5 modulators and methods of use thereof
AU2009316484B2 (en) * 2008-11-19 2015-04-16 Intercept Pharmaceuticals, Inc. TGR5 modulators and methods of use thereof
NZ707389A (en) 2012-10-26 2018-08-31 Intercept Pharmaceuticals Inc Process for preparing bile acid derivatives

Also Published As

Publication number Publication date
US10202414B2 (en) 2019-02-12
NZ707389A (en) 2018-08-31
PL2912013T3 (pl) 2018-05-30
EP2912013B1 (en) 2017-10-11
IL238454A0 (en) 2015-06-30
DK2912013T3 (en) 2018-01-15
NO2968302T3 (enExample) 2018-02-03
SMT201700602T1 (it) 2018-03-08
KR20150074062A (ko) 2015-07-01
JP6272888B2 (ja) 2018-01-31
CY1119731T1 (el) 2018-06-27
CN108250264A (zh) 2018-07-06
PT2912013T (pt) 2018-01-03
MX2015005286A (es) 2015-10-29
US20180079776A1 (en) 2018-03-22
KR102068381B1 (ko) 2020-01-20
US20150291653A1 (en) 2015-10-15
EP2912013A4 (en) 2016-06-01
SG11201503247UA (en) 2015-06-29
EP2912013A1 (en) 2015-09-02
US9777038B2 (en) 2017-10-03
AU2013334122A1 (en) 2015-05-14
CN105102425B (zh) 2018-04-10
WO2014066819A1 (en) 2014-05-01
HK1214239A1 (zh) 2016-07-22
HUE036887T2 (hu) 2018-08-28
ES2655034T3 (es) 2018-02-16
CN105102425A (zh) 2015-11-25
NZ745013A (en) 2019-08-30
MX361653B (es) 2018-12-13
HK1253301A1 (zh) 2019-06-14
JP2015533852A (ja) 2015-11-26
IL238454B (en) 2018-11-29
BR112015009395A2 (pt) 2017-07-04
AU2013334122B2 (en) 2017-11-02

Similar Documents

Publication Publication Date Title
EP2912013B1 (en) Process for preparing bile acid derivatives
KR100555970B1 (ko) 2-아미노-1,3-프로판디올유도체의 제조방법
RU2624007C2 (ru) Способ получения улипристала ацетата и его промежуточных продуктов
JP2635213B2 (ja) 化学工程
JP5717752B2 (ja) ピリピロペン誘導体の製造法
PL200165B1 (pl) Sposób wytwarzania estrów nitroksyalkilowych naproksenu oraz ester nitroksybutylowy kwasu 2-(S)-(6-metoksy-2-naftylo)propanowego o wysokim nadmiarze enancjomerycznym
PL130559B1 (en) Process for preparing pure isosorbite 5-nitrate
US3538120A (en) Cyclopentyl-alkanoic acids
CN110551133A (zh) 叔丁基-5-(羟甲基)-7-氧杂-2-氮杂螺[3.5]壬烷-2-甲酸基酯的制法
DK170233B1 (da) Fremgangsmåde til fremstilling af alkoxymethylether- og alkoxymethylesterderivater af glyceroler
EP0243646B1 (en) A process for the preparation of forskolin from 9-deoxy-forskolin and intermediates used therein
CN109134577B (zh) 一种3α-羟基-5α-胆烷酸的合成方法
AU2006272420A1 (en) Method for producing nebivolol
US5072008A (en) Manufacture of lactol derivatives
PL243187B1 (pl) Sposób i związki pośrednie do otrzymywania menachinonu MK-7
HK1214239B (en) Process for preparing bile acid derivatives
US4906759A (en) Process for the production of 4-alkoxy-2(5H) thiophenones
Beccalli et al. 4-Azidotetronic Acids: A New Class of Azido Derivatives
JP2005314260A (ja) フラボンc配糖体の製法
CN101575287B (zh) 一种辛伐他汀铵盐的合成方法及所用中间体及其制备方法
Yamagata et al. Rhodium (II) acetate‐catalyzed reaction of 2‐amino‐4, 5‐dihydro‐3‐furancarbonitriles with dialkyl diazomalonates
Ye et al. Expedient Construction of the Ziegler Intermediate Useful for the Synthesis of Forskolin via Consecutive Rearrangements
US5008407A (en) Method of synthesizing forskolin from 9-deoxyforskolin
PL197215B1 (pl) Nowy chiralny bromospirolakton karanu i sposób jego wytwarzania
CN102690254A (zh) 辛伐他汀铵盐中间体及其制备方法

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180705

FZDE Discontinued

Effective date: 20220502